HCPCS code C1819 – Surgical tissue localization and excision device

Key takeaways

HCPCS code C1819 covers single-use implantable tissue localization devices placed before surgical excision, distinct from reusable guidance instruments or wire localizers.

C1819 is restricted to hospital outpatient departments and ASCs under OPPS and the ASC payment system. Physician offices cannot bill this code.

CMS packaging rules may bundle the device cost into the procedure payment. Verify the current OPPS addendum before assuming separate reimbursement.

The operative report is the element most often missing from denied C1819 claims, so it belongs in the charge capture check.

Practice management software like Pabau tracks device-code claims, flags packaging status changes, and keeps the documentation checklist in one place.

HCPCS code C1819: Official descriptor and code classification

HCPCS code C1819 carries the official descriptor: Surgical tissue localization and excision device (implantable).

It sits within HCPCS Level II, the code set maintained by the Centers for Medicare and Medicaid Services (CMS). HCPCS Level II captures supplies, devices, and services not described by CPT codes. C-series codes like C1819 are temporary outpatient codes created for the Hospital Outpatient Prospective Payment System (OPPS) and the ASC payment system.

The reference table below summarizes the classification attributes coders need when setting up the code in a chargemaster or submitting a claim.

What devices and procedures does HCPCS code C1819 cover?

C1819 covers single-use implantable devices placed inside the body before surgical excision. They mark or guide removal of a tissue target, most commonly a breast lesion. The device remains in the patient temporarily and is removed or retrieved during surgery. It is not a permanent implant.

Device categories that typically fall under C1819 include radar-reflector localizers, magnetic seed localizers, and radioactive seed localizers used for pre-surgical lesion marking. Radiology places these percutaneously before the operative procedure, and they serve as the target for the surgeon during excision.

Not every localizer maps to C1819. The code applies when the device is implantable or insertable and is used specifically for tissue localization and excision guidance. Non-implantable guidance tools, such as certain external ultrasound guidance systems, and reusable instruments do not qualify.

C1819 vs C1820: How to choose the correct HCPCS code

C1819 covers implantable tissue localization devices used for excision guidance. C1820 is a separate HCPCS code that describes a surgical tissue localization and excision device that is not implantable. The distinction is device construction. If the localization device stays inside the body until it is retrieved during surgery, use C1819. If the device is placed externally or does not meet the implantable definition, verify whether C1820 or another adjacent code applies.

When in doubt, review the device manufacturer’s specifications first. Then confirm the device category in the current CMS HCPCS code file or via the AAPC HCPCS code lookup.

Care settings eligible to bill C1819

C1819 is restricted to facility claims from hospital outpatient departments, billed under OPPS, and ambulatory surgery centers, billed under the ASC payment system. Physician offices, independent practices, and freestanding imaging centers cannot bill this code on a professional claim.

• Hospital outpatient department: Bill C1819 on the facility UB-04 claim alongside the companion procedure CPT code. Payment is governed by the OPPS APC assignment for the procedure.
• ASC: ASCs may bill C1819 when the procedure is on the CMS-approved ASC covered procedures list. The ASC payment indicator decides whether payment is packaged, separately payable, or not covered in that setting. Verify the indicator in the current ASC payment rates file.
• Physician office or freestanding practice: These settings cannot bill C-series HCPCS device codes. Device costs here are typically wrapped into the professional fee or billed through alternate mechanisms.

The C-series restriction exists because C-codes were created for the OPPS framework. Submitting a C-code on a CMS-1500 from a physician office will generate an edit error and denial. Before submission, confirm that the claim form, the billing NPI, and the facility taxonomy match the outpatient setting.

Three checks decide whether a C1819 line will pay, and two of them are settled before the claim form is chosen.

Medicare and payer reimbursement for HCPCS code C1819

Medicare reimburses C1819 under OPPS through the APC (Ambulatory Payment Classification) assigned to the companion procedure, unless C1819 qualifies for separate pass-through payment. Pass-through status for device C-codes is temporary and lasts a maximum of three years from the date CMS grants it. After it expires, the device cost is packaged into the procedure APC payment.

Two practical steps come before billing:

• Check the current OPPS addendum (Addendum B) on the CMS website for C1819’s status indicator. A status indicator of “H” signals a device with pass-through payment, and “N” signals a cost packaged into the procedure payment.
• Confirm the current payment rate for the applicable CMS fiscal year. Payment rates change with each OPPS final rule, so never rely on prior-year figures without verification.

Commercial and Medicaid payer coverage for C1819 varies. Some plans follow Medicare OPPS logic. Others have separate medical policies that govern device code reimbursement or require prior authorization. Always verify individual payer policy before assuming commercial coverage mirrors Medicare rates.

CPT codes commonly billed alongside C1819

C1819 is a device code and does not describe a procedure on its own. It is always billed alongside a companion CPT procedure code on the same facility claim. The CPT code identifies what the surgeon did, and C1819 identifies the implantable device used to accomplish it.

Common companion CPT codes include:

• 19125 / 19126: Excision of breast lesion identified by preoperative placement of radiological marker, open; single lesion / each additional lesion
• 19301: Mastectomy, partial (lumpectomy, tylectomy, quadrantectomy, segmentectomy), without axillary lymph node dissection
• 19302: Mastectomy, partial, with complete axillary lymph node dissection
• 19110: Nipple exploration with or without excision of a solitary lactiferous duct or a papilloma therein
• 19120: Excision of cyst, fibroadenoma, or other benign or malignant tumor, aberrant breast tissue, duct lesion, nipple or areolar lesion

Sequence the device code (C1819) after the primary procedure CPT code on the claim. Payers expect the procedure to drive medical necessity and the device code to follow as a supply item. Proper sequencing reduces the chance of an edit rejecting the claim before adjudication. Coordinate with your coding and OR supply chain teams to capture the device unit cost and lot number at implantation.

ICD-10 diagnosis codes that support C1819 claims

Payers adjudicating C1819 claims expect an ICD-10-CM diagnosis code that supports the medical necessity of surgical localization and excision. Breast neoplasm codes are the most common pairing, because most C1819 claims arise from breast lesion localization performed before lumpectomy or excisional biopsy.

Specificity matters. Code to the highest level of specificity the clinical documentation supports. If the operative report and pathology documents identify laterality and site, the diagnosis code must reflect that. Using an unspecified code when the record supports a specific one is an audit flag for Medicare and commercial payers alike.

Documentation requirements for billing HCPCS code C1819

Complete documentation separates a clean C1819 claim from a denial or a post-payment audit finding. The medical record must support every element of the claim. The device was implantable, it was used for surgical tissue localization and excision guidance, and it was implanted during the billed encounter.

The following elements must appear in the medical record to support a C1819 claim. Meeting clean claim standards for device codes takes radiology, OR nursing, and coding working together, since each group captures a different part of the record.

• Radiology / interventional procedure report: Documents device type (brand and model if possible), anatomical placement site, laterality, date, and radiological confirmation of placement.
• Operative report: Confirms the surgeon retrieved or used the localization device during the excisional procedure. Notes the device type and the tissue target excised. This is the element most commonly missing in denied C1819 claims.
• Implant log or device sticker: The device UDI (Unique Device Identifier), lot number, and unit cost belong in the OR implant log. A device label affixed to the operative record serves the same purpose.
• Pathology report: Confirms excision of the targeted tissue, supporting the clinical necessity of the localization procedure.
• Physician order: A signed order for the localization procedure before the operative date, documenting the clinical indication.

Prior authorization requirements for C1819

Medicare does not require prior authorization for HCPCS code C1819 as a standalone device code under standard OPPS billing. The companion surgical procedure, such as a partial mastectomy, may still require authorization from the Medicare Advantage plan or commercial payer. Authorization for the procedure generally covers the device when it is integral to that procedure.

Commercial and Medicaid managed care payers are another matter. Many have separate medical policies for tissue localization devices. Some plans require the facility to confirm which device technology is being used, and that the device meets their coverage criteria before the placement date. Check prior-authorization requirements for both the device and the companion excision procedure at scheduling.

Requirements change frequently. Build a process for verifying payer-specific authorization requirements each time a new device technology joins your facility’s supply chain.

Common claim denial reasons for C1819 and how to prevent them

C1819 denials cluster around four root causes. Each one is preventable once the coding and clinical teams coordinate on charge capture.

• Wrong billing setting: A physician office or freestanding practice submits C1819 on a CMS-1500, where C-codes generate an edit error. Fix: confirm the claim originates from a hospital outpatient or ASC facility NPI.
• Device cost packaged into procedure payment: The payer’s OPPS addendum status indicator shows “N” (packaged). The device cost is then already bundled into the APC payment for the companion procedure. Billing C1819 separately produces a denial. Fix: check the current-year OPPS status indicator before submitting.
• Missing or incomplete implant documentation: The operative report does not name the device, or the implant log is absent from the record. Fix: implement the documentation checklist described in the prior section.
• Incorrect or unsupported diagnosis pairing: The ICD-10-CM code on the claim does not support the medical necessity of a tissue localization procedure. Fix: code to the highest specificity the clinical documentation supports, and review the denial codes that commonly accompany device claim rejections.

Billing tips and compliance considerations for implantable device billing

Implantable device billing under HCPCS code C1819 depends on departments that do not always communicate automatically. Three habits carry most of the weight for outpatient facilities billing C-codes: chargemaster accuracy, an OR-to-coding handoff, and annual OPPS verification.

Chargemaster accuracy: Confirm that C1819 is mapped to the correct revenue code in the chargemaster, and that the charge description reflects only implantable localization devices. A catch-all device charge that maps several device types to C1819 creates upcoding exposure. Keep the chargemaster device codes current each year, once the OPPS final rule is published.

OR-to-coding handoff: Establish a formal process where OR nursing captures device brand, model, and UDI at the time of implantation. That information then routes to the coding team before claim submission. Coders should not be reconstructing device details from a partial operative note.

Annual OPPS verification: CMS targets around November 1 for the OPPS final rule, which takes effect the following January 1. Recent years have slipped to mid or late November. Packaging status for C-codes can change with it. Build an annual review into the chargemaster update cycle, so C1819’s payment status is verified before the first claim of the new calendar year. Claims management software with payer rule tracking reduces the manual effort of monitoring these changes.

How Pabau keeps C1819 device claims clean before submission

Most facilities track a device claim across three systems. The radiology report sits in imaging, the implant log sits with OR nursing, and the charge sits in the chargemaster. Coders reconcile the three by hand, often after the claim has already gone out.

Pabau, our practice management software, keeps the encounter, the clinical documentation, and the claim in one record. Coders can see whether the operative report names the device before the charge is released, rather than after a payer sends it back.

Claim status and denial reasons sit in the same place. A packaging change that starts denying C1819 lines shows up as a pattern instead of a run of one-off write-offs. Billing teams get the evidence to fix the chargemaster mapping once, instead of appealing claim by claim.

Streamline HCPCS billing across your outpatient facility

Pabau’s claims management tools track device-code claims, monitor packaging status changes, and surface missing documentation before submission. ASC and hospital outpatient teams get fewer denials and a cleaner C-code workflow.

Book a demo

Conclusion

Two of the three checks on a C1819 claim can be settled long before the patient is in the room. The device either meets the implantable definition or it does not. The facility either bills under OPPS or the ASC payment system, or it cannot bill the code at all. The third check, packaging status, moves with each OPPS final rule, so it belongs in the annual chargemaster review rather than in a coder’s memory.

What decides most C1819 denials is the operative report, and no billing rule fixes that from the coding desk. Get the OR to name the device and log the UDI at the time of implantation, and the rest of the claim follows. Book a demo to see how Pabau keeps device documentation and claim status in one record for outpatient and ASC billing teams.

Continue your research

Need device documentation that holds up to an audit? Medical billing compliance sets out the laws and violations that shape how practices document and bill implantable devices.

Want fewer denials on implantable device claims? Denial management in healthcare walks through the five-step process for finding, appealing, and preventing denied claims.

Curious how a device charge travels from the OR to the remittance? Revenue cycle management covers the seven steps from charge capture through payment posting.

Frequently asked questions